Shares of Ariad Pharmaceuticals (ARIA +2.9%) move higher after the firm announces long-term...

|By:, SA News Editor

Shares of Ariad Pharmaceuticals (ARIA +2.9%) move higher after the firm announces long-term results of a Phase 1 trial of its leukemia treatment.